JAMDA
Volume 5, Issue 1 , Pages 31-37 , January 2004

Corticosteroids and Chronic Obstructive Pulmonary Disease in the Nursing Home

  • Allegra Rich, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Allegra Rich, MD, Geriatric Medicine Fellow, University of California, Los Angeles, 11926 Goshen Ave. #8, Los Angeles, CA 90049.

References 

  1. National Heart, Lung, and Blood Institute  . Morbidity and Mortality Chartbook on Cardiovascular, Lung and Blood Diseases . Bethesda, MD: US Department of Health and Human Services, National Institutes of Health; 1998;
  2. McCrory D , Brown C , Gelfand S , et al.   Management of acute exacerbations of COPD . Chest . 2001;119:1190–1209
  3. Statistical Abstract of the United States . Springfield, VA: US Department of Commerce, Bureau of Census; 1997;
  4. Agency for Health Care Research and Policy  . Healthcare Cost and Utilization Project: Nationwide Inpatient Sample for 1997 . National Technical Information Service; 1997;
  5. The National Lung Health Education Program. Strategies in preserving lung health prevention COPD and associated diseases . Chest . 1998;113:123S–163S
  6. Pauwels R , Buist S , Calverly P , et al.   Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary . Am J Respir Crit Care Med . 2001;163:1257–1276
  7. MacNee W , Calverly P . Chronic obstructive pulmonary disease 7: Management of COPD . Thorax . 2003;58:261–265
  8. National Heart, Lung, and Blood Institute  . Guidelines for the Diagnosis and Management of Asthma . NAEPP Expert Panel Report 2002 . Bethesda, MD: US Department of Health and Human Services, National Institutes of Health; 2002;
  9. Pauwels R , Lofdahl C , Laitinen L , et al.   Long term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking . N Engl J Med . 1999;320:1948–1953
  10. Burge P , Calverley P , Jones P , et al.   Randomized, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial . BMJ . 2000;320:1297–1303
  11. Paggiaro P , Dahle R , Bakran I , et al.   Multi-center randomized placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease . Lancet . 1998;351:773–780
  12. Vestbo J , Sorensen T , Lange P , et al.   Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomized controlled trial . Lancet . 1999;353:1819–1823
  13. The Lung Health Research Group  . Effect of inhaler triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease . N Engl J Med . 2000;343:1902–1909
  14. Jones P , Quirk F , Baveystock G . The St. George's respiratory questionnaire . Respir Med . 1991;85(suppl B):25–31
  15. Calverley P , Pauwels R , Vestbo J , et al.   Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: A randomized controlled trial . Lancet . 2003;361:449–456
  16. Sin D , Tu J . Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease . Am J Crit Care Med . 2001;164:580–584
  17. Decramer M , Lacquet L , Fagard R , et al.   Corticosteroids contribute to muscle weakness in chronic airflow obstruction . Am J Respir Crit Care Med . 1994;150:11–16
  18. Rice K , Rubins J , Lebahn R , et al.   Withdrawal of chronic systemic corticosteroids in patients with COPD . Am J Respir Crit Care Med . 2000;162:174–178
  19. Renkema T , Schouten J , Koeter GE , et al.   Effects of long-term treatment with corticosteroids in COPD . Chest . 1996;109:1156–1162
  20. Niewoehner D , Erbland M , Deupree R , et al.   Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease . N Engl J Med . 1999;340:1941–1947
  21. Davies L , Angus R , Calverley P . Oral corticosteroids for patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomized controlled trial . Lancet . 1999;354:456–460
  22. Thompson W , Nielson C , Carvalho P , et al.   Controlled trial of oral prednisone in outpatients with acute COPD exacerbation . Am J Crit Care Med . 1996;154:407–412
  23. Aaron S , Vandemheen K , Hebert P , et al.   Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease . N Engl J Med . 2003;348:2618–2625
  24. Maltais F , Ostinelli J , Boureau J , et al.   Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease . Am J Respir Crit Care Med . 2002;165:698–703
  25. Biskobing D . COPD and osteoporosis . Chest . 2002;121:609–620
  26. Singh J , Palda V , Stanbrook M , et al.   Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease . Arch Intern Med . 2002;162:2527–2536
  27. McEvoy C , Ensrud K , Bender E , et al.   Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease . Am J Respir Crit Care Med . 1998;157:704–709
  28. Hubbard R , Smith C , Smeeth L , et al.   Inhaled corticosteroids and hip fracture . Am J Respir Crit Care Med . 2002;166:1563–1566
  29. Van Staa T , Leufkens H , Cooper C . Use of inhaled corticosteroids and risk of fractures . Bone Miner Res . 2001;16:581–588
  30. Global Initiative for Chronic Obstructive Pulmonary Disease. Global Strategy for Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report. Bethesda, MD: National Heart Lung and Blood Institute, April 2001. Update of the Management Sections, GOLD web site (www.goldcopd.com) Updated July 1, 2003.

PII: S1525-8610(04)70041-9

JAMDA
Volume 5, Issue 1 , Pages 31-37 , January 2004

Article Tools